Contribution: Industrial Research Assistance Program – Contributions to Firms
Pividl Bioscience Inc.
$75,000.00
Developing Novel Nano Formulations of Poorly Soluble Active Ingredients To Act As Anti-Inflammatory And Antioxidant Agents in Humans.
FY 2025-26 · 2025-06-01
Summary
Pividl's Micellosomes are a novel nano-delivery system used to deliver hard to solubilize and poorly bioavailable compounds. This project is aimed at demonstrating how Micellosomes can be used to deliver anti-inflammatory molecules that have the potential to provide radiation protection and reduce the impacts of radiation / inflammation exposure on and in the human body. Formulations produced will be standardised and validated for stability, encapsulation efficiency and bioavailability kinetics in order to demonstrate their ability to prevent and reduce radiation induced inflammation in Microvascular endothelial cells and anti-inflammatory responses in human Embryonic kidney cells, cardiovascular cells and blood-brain-barrier cells.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Moncton|Moncton, New Brunswick, Canada
Recipient Type
For-profit organization
Business Number
730916079
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2026-02-28
Agreement Number
1031138
Agreement Start Date
2025-06-01
Agreement Title
Developing Novel Nano Formulations of Poorly Soluble Active Ingredients To Act As Anti-Inflammatory And Antioxidant Agents in Humans.
Agreement Title (French)
Développement de nouvelles formulations nanométriques d’ingrédients actifs peu solubles pour agir comme agents anti-inflammatoires et antioxydants chez l’homme.
Agreement Type
Contribution
Agreement Value
$75,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Pividl's Micellosomes are a novel nano-delivery system used to deliver hard to solubilize and poorly bioavailable compounds. This project is aimed at demonstrating how Micellosomes can be used to deliver anti-inflammatory molecules that have the potential to provide radiation protection and reduce the impacts of radiation / inflammation exposure on and in the human body. Formulations produced will be standardised and validated for stability, encapsulation efficiency and bioavailability kinetics in order to demonstrate their ability to prevent and reduce radiation induced inflammation in Microvascular endothelial cells and anti-inflammatory responses in human Embryonic kidney cells, cardiovascular cells and blood-brain-barrier cells.
Description (French)
Les micellosomes de Pividl sont un nouveau système de nano-administration utilisé pour administrer des composés difficiles à solubiliser et peu biodisponibles. Ce projet vise à démontrer comment les micellosomes peuvent être utilisés pour administrer des molécules anti-inflammatoires susceptibles d’assurer une protection contre les rayonnements et de réduire les effets de l’exposition aux rayonnements/inflammations sur et dans le corps humain. Les formulations produites seront standardisées et validées en termes de stabilité, d’efficacité d’encapsulation et de cinétique de biodisponibilité afin de démontrer leur capacité à prévenir et à réduire l’inflammation induite par les rayonnements dans les cellules endothéliales microvasculaires et les réponses anti-inflammatoires dans les cellules rénales embryonnaires humaines, les cellules cardiovasculaires et les cellules de la barrière hémato-encéphalique.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Moncton--Riverview--Dieppe
Federal Riding (French)
Moncton--Riverview--Dieppe
Federal Riding Number
13007
NAICS Code
33149
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
730916079
Recipient City
Moncton|Moncton
Recipient Country
CA
Recipient Legal Name
Pividl Bioscience Inc.
Recipient Postal Code
E1C 4X7
Recipient Province or Territory
NB
Recipient Type
F
Reference Number
172-2025-2026-Q1-1031138
